Air-Liquid Interface Cell Exposures to Nanoparticle Aerosols

Area of Science:

• Nanomedicine
• Inhalation Toxicology
• Biotechnology

Background:

• Nanomedicine shows promise for drug delivery, but inhaled nanoparticle formulations struggle with market translation compared to intravenous routes.
• Safety concerns are a significant barrier to the clinical approval and development of inhaled nanomedicines.
• In vitro air-liquid interface (ALI) systems are emerging as valuable tools for assessing nanoparticle aerosol toxicity, complementing traditional animal models.

Purpose of the Study:

• To describe an air-liquid interface (ALI) cell exposure assay for evaluating toxicological effects of nanoparticle aerosols.
• To assess key toxicological endpoints including cell viability and oxidative stress.
• To provide a method for the rapid safety assessment of candidate inhaled nanomedicines.

Main Methods:

• Utilized an air-liquid interface (ALI) cell culture model to expose lung cells to nanoparticle aerosols.
• Quantified cell viability using standard assays to determine cytotoxic effects.
• Measured oxidative stress markers to evaluate cellular responses to nanoparticle exposure.

Main Results:

• The ALI assay demonstrated measurable toxicological effects, including impacts on cell viability.
• Oxidative stress was identified as a key endpoint affected by nanoparticle aerosol exposure.
• The assay provides a reproducible method for assessing nanoparticle aerosol toxicity.

Conclusions:

• The described ALI cell exposure assay is a viable method for assessing the toxicity of inhaled nanoparticle aerosols.
• This in vitro approach can aid in the early-stage safety evaluation of nanomedicines intended for inhalation.
• Further development and validation of ALI assays can accelerate the translation of inhaled nanomedicines.